Author

Lisa Nocquet

Centre National de la Recherche ScientifiqueORCID 0000-0002-2371-209XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chloé C. LefebvreiD· 1 shared Frédérique SouazéiD· 1 shared Julie Roul· 1 shared Laurine Duarte· 1 shared Mario CamponeiD· 1 shared Philippe Paul JuiniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chloé C. LefebvreORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyScientific ReportsPeer-reviewedJun 19, 2024

Cancer associated fibroblasts mitigate the efficacy of the combination treatment of chemotherapy and BCL-xL targeting in triple negative breast cancer cells

Lisa Nocquet, Julie Roul, Chloé C. Lefebvre…·Frédérique Souazé

This study shows that BCL-xL promotes chemotherapy resistance in TNBC cells, and CAFs reduce the effectiveness of chemotherapy combined with BCL-xL inhibition.

26 citations

humanbulk RNA-seq

𝕏 PostBluesky